Introduction: Methylone (3,4-methylenedioxymethcathinone) is a new psychoactive substance and an active ingredient of "legal highs" or "bath salts". We studied the pharmacokinetics and locomotor activity of methylone in rats at doses equivalent to those used in humans. Material and methods: Methylone was administered to male Sprague-Dawley rats intravenously (10 mg/kg) and orally (15 and 30 mg/kg). Plasma concentrations and metabolites were characterized by LC/MS and LC-MS/MS fragmentation patterns. Locomotor activity was monitored for 180-240 min. Results: Oral administration of methylone induced a dose-dependent increase in locomotor activity in rats. The plasma concentrations after i.v. administration were described by a two-compartment model with distribution and terminal elimination phases of α = 1.95 h −1 and β = 0.72 h −1
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. For oral administration, peak methylone concentrations were achieved between 0.5 and 1 h and fitted to a flip-flop model. Absolute bioavailability was about 80% and the percentage of methylone protein binding was of 30%. A relationship between methylone brain levels and free plasma concentration yielded a ratio of 1.42 ± 0.06, indicating access to the central nervous system. We have identified four Phase I metabolites after oral administration. The major metabolic routes are N-demethylation, aliphatic hydroxylation and O-methylation of a demethylenate intermediate. Discussion: Pharmacokinetic and pharmacodynamic analysis of methylone showed a correlation between plasma concentrations and enhancement of the locomotor activity. A contribution of metabolites in the activity of methylone after oral administration is suggested. Present results will be helpful to understand the time course of the effects of this drug of abuse in humans.
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Introduction
A new generation of designer phenethylamine derivatives, known as "legal highs" or "research chemicals" has emerged and has been marketed as a legal alternative to "ecstasy" (3,4-methylenedioxymethamphetamine or MDMA) or cocaine. Their chemical structure is related to cathinone, the main psychoactive constituent of khat (Sørensen, 2011) . These products are also advertised as "bath salts", the active ingredients of which include mephedrone, methylone and MDPV (3,4-methylenedioxypyrovalerone) alone or mixed (Spiller et al., 2011) , available for purchase on line, at convenience stores or truck stops. In October 2011, the Drug Enforcement Administration (DEA) placed these three synthetic cathinones (mephedrone, methylone and MDPV) and their salts and isomers into the Schedule I of the Controlled Substances Act, to avoid an imminent hazard to the public safety. In October 2012, the DEA extended the temporary placement of methylone into this schedule.
The most commonly available cathinone derivatives sold on the recreational market appear to be mephedrone (4-methyl-methcathinone) and methylone (3,4-methylenedioxymethcathinone) (Brunt et al., 2010) . Methylone was first synthesized as an antidepressant and taken orally or nasally, as drug of abuse, emerged under the trade name "explosion" around 2004 thus making it one of the first products to be marketed via on-line (Bossong et al., 2005) .
Previous studies have described that cathinone users consider the effects of these new drugs of abuse to be superior to those of cocaine and MDMA (Vardakou et al., 2011; Winstock et al., 2010) and it may explain their rapid rise in popularity. E-mail address: eescubedo@ub.edu (E. Escubedo).
